Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.
2.
3.

Metal catalyst-free substitution of allylic and propargylic phosphates with diarylmethyl anions.

Kawashima H, Ogawa N, Saeki R, Kobayashi Y.

Chem Commun (Camb). 2016 Apr 7;52(27):4918-21. doi: 10.1039/c6cc00024j. Epub 2016 Mar 15.

PMID:
26975239
4.

Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.

Li X, Saeki R, Watari A, Yagi K, Kondoh M.

Eur J Pharm Sci. 2014 Feb 14;52:132-7. doi: 10.1016/j.ejps.2013.10.018. Epub 2013 Nov 11.

PMID:
24231339
5.

A claudin-targeting molecule as an inhibitor of tumor metastasis.

Saeki R, Kondoh M, Kakutani H, Matsuhisa K, Takahashi A, Suzuki H, Kakamu Y, Watari A, Yagi K.

J Pharmacol Exp Ther. 2010 Aug;334(2):576-82. doi: 10.1124/jpet.110.168070. Epub 2010 May 4.

PMID:
20442222
6.

Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin.

Kakutani H, Kondoh M, Saeki R, Fujii M, Watanabe Y, Mizuguchi H, Yagi K.

Eur J Pharm Biopharm. 2010 Jun;75(2):213-7. doi: 10.1016/j.ejpb.2010.03.003. Epub 2010 Mar 11.

PMID:
20226859
7.

A novel tumor-targeted therapy using a claudin-4-targeting molecule.

Saeki R, Kondoh M, Kakutani H, Tsunoda S, Mochizuki Y, Hamakubo T, Tsutsumi Y, Horiguchi Y, Yagi K.

Mol Pharmacol. 2009 Oct;76(4):918-26. doi: 10.1124/mol.109.058412. Epub 2009 Jul 28.

PMID:
19638534
8.

Mutagenicity of anaerobic fenitrothion metabolites after aerobic biodegradation.

Matsushita T, Matsui Y, Saeki R, Inoue T.

Chemosphere. 2005 Dec;61(8):1134-41. Epub 2005 Apr 13.

PMID:
16263383
9.

Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning.

Saeki R, Nagai H, Kaneko S, Unoura M, Yamanaka N, Okamoto E, Kobayashi K, Matsubara K.

J Hepatol. 2000 Jul;33(1):99-105.

PMID:
10905592
10.
11.

Clinical pathoepidemiology of hepatocellular carcinoma in Japan.

Kobayashi K, Ooba S, Saeki R, Minouchi K, Kaneko S, Inagaki Y, Unoura M.

Princess Takamatsu Symp. 1995;25:67-74.

PMID:
8875611
12.

Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis.

Nagai H, Ponglikitmongkol M, Mita E, Ohmachi Y, Yoshikawa H, Saeki R, Yumoto Y, Nakanishi T, Matsubara K.

Cancer Res. 1994 Mar 15;54(6):1545-50.

13.

Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report.

Saeki R, Kaneko S, Terasaki S, Unoura M, Ogino H, Wakabayashi T, Kawara S, Nakanuma Y, Kobayashi K.

Hepatogastroenterology. 1993 Oct;40(5):499-501.

PMID:
8270244
14.

Detection of chemiluminescence in lipid peroxidation of biological systems and its application to HPLC.

Miyazawa T, Saeki R, Inaba H.

J Biolumin Chemilumin. 1989 Jul;4(1):475-8.

PMID:
2801234
15.

Assessment of the viability of liver allografts by chemiluminescence.

Ohkohchi N, Kanno M, Terashima T, Taguchi Y, Mori S, Saeki R, Usa T, Inaba H, Miyazawa T.

Transplant Proc. 1989 Feb;21(1 Pt 2):1332-4. No abstract available.

PMID:
2652440
16.

[A therapeutic trial in a case of alveolar proteinosis: successful treatment with frequent transbronchial liquid infusion].

Saeki R, Nishina M, Endo K, Haneda Y, Saito H.

Kokyu To Junkan. 1984 Feb;32(2):171-7. Japanese. No abstract available.

PMID:
6463407
17.

[Studies on unutilized resources. V. The components of the flavonoids in Chenopodium genus plants. 1. Flavonoids of Chenopodium ambrosioides L].

Arisawa M, Minabe N, Saeki R, Takakuwa T, Nakaoki T.

Yakugaku Zasshi. 1971 May;91(5):522-4. Japanese. No abstract available.

PMID:
5105136
18.

Glucose-metabolizing enzymes in Yoshida sarcoma and its slow-growing variant subline.

Takeda H, Sato K, Saeki R, Suzuki R, Tsuiki S.

Gan. 1967 Oct;58(5):459-66. No abstract available.

PMID:
4295564

Supplemental Content

Support Center